Larson S - Search Results

1

Phase I evaluation of J591 as a vascular targeting agent in progressive solid tumors.

Morris MJ, Pandit-Taskar N, Divgi CR, Bender S, O'Donoghue JA, Nacca A, Smith-Jones P, Schwartz L, Slovin S, Finn R, Larson S, Scher HI. Morris MJ, et al. Among authors: larson s. Clin Cancer Res. 2007 May 1;13(9):2707-13. doi: 10.1158/1078-0432.CCR-06-2935. Clin Cancer Res. 2007. PMID: 17473203 Clinical Trial.

2

Hormone refractory prostatic cancer: the role of radiolabelled diphosphonates and growth factor inhibitors.

Scher HI, Curley T, Yeh S, Tong W, O'Moore PV, Larson S. Scher HI, et al. Among authors: larson s. Adv Exp Med Biol. 1992;324:115-29. doi: 10.1007/978-1-4615-3398-6_12. Adv Exp Med Biol. 1992. PMID: 1283494 Review. No abstract available.

3

Therapeutic alternatives for hormone-refractory prostatic cancer.

Scher HI, Curley T, Yeh S, Iversen JM, O'Dell M, Larson SM. Scher HI, et al. Among authors: larson sm. Semin Urol. 1992 Feb;10(1):55-64. Semin Urol. 1992. PMID: 1373515 Review.

4

PET scanning of iodine-124-3F9 as an approach to tumor dosimetry during treatment planning for radioimmunotherapy in a child with neuroblastoma.

Larson SM, Pentlow KS, Volkow ND, Wolf AP, Finn RD, Lambrecht RM, Graham MC, Di Resta G, Bendriem B, Daghighian F, et al. Larson SM, et al. J Nucl Med. 1992 Nov;33(11):2020-3. J Nucl Med. 1992. PMID: 1432165 Free article.

5

Detection of hepatic metastases from colorectal carcinoma using indium-111 (111In) labeled monoclonal antibody (mAb): MSKCC experience with mAb 111In-C110.

Divgi CR, McDermott K, Johnson DK, Schnobrich KE, Finn RD, Cohen AM, Larson SM. Divgi CR, et al. Among authors: larson sm. Int J Rad Appl Instrum B. 1991;18(7):705-10. doi: 10.1016/0883-2897(91)90008-9. Int J Rad Appl Instrum B. 1991. PMID: 1787079

6

Estimates of radiation absorbed dose for intraperitoneally administered iodine-131 radiolabeled B72.3 monoclonal antibody in patients with peritoneal carcinomatoses.

Larson SM, Carrasquillo JA, Colcher DC, Yokoyama K, Reynolds JC, Bacharach SA, Raubitchek A, Pace L, Finn RD, Rotman M, et al. Larson SM, et al. J Nucl Med. 1991 Sep;32(9):1661-7. J Nucl Med. 1991. PMID: 1880565 Free article.

7

Radioimmunodetection of neuroblastoma with iodine-131-3F8: correlation with biopsy, iodine-131-metaiodobenzylguanidine and standard diagnostic modalities.

Yeh SD, Larson SM, Burch L, Kushner BH, Laquaglia M, Finn R, Cheung NK. Yeh SD, et al. Among authors: larson sm. J Nucl Med. 1991 May;32(5):769-76. J Nucl Med. 1991. PMID: 1902508 Free article.

8

Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma.

Divgi CR, Welt S, Kris M, Real FX, Yeh SD, Gralla R, Merchant B, Schweighart S, Unger M, Larson SM, et al. Divgi CR, et al. Among authors: larson sm. J Natl Cancer Inst. 1991 Jan 16;83(2):97-104. doi: 10.1093/jnci/83.2.97. J Natl Cancer Inst. 1991. PMID: 1988695

9

Radioimmunology. Imaging and therapy.

Larson SM. Larson SM. Cancer. 1991 Feb 15;67(4 Suppl):1253-60. doi: 10.1002/1097-0142(19910215)67:4+<1253::aid-cncr2820671523>3.0.co;2-j. Cancer. 1991. PMID: 1991286 Review.

10

Technical challenges associated with the radiolabeling of monoclonal antibodies utilizing short-lived, positron emitting radionuclides.

Finn R, Cheung NK, Divgi C, St Germain J, Graham M, Pentlow K, Larson SM. Finn R, et al. Among authors: larson sm. Int J Rad Appl Instrum B. 1991;18(1):9-13. doi: 10.1016/0883-2897(91)90040-r. Int J Rad Appl Instrum B. 1991. PMID: 2010313 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,851 results

Search Page

Filters